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Income inequality in uptake of voluntary
versus organised breast cancer screening:
evidence from the British Household Panel
Survey
Patricia Carney1 and Ciaran O’Neill2*
Abstract
Background: This paper measures income-related inequality in uptake of breast cancer screening among women
before and after a policy change to extend the screening programme to women aged 65 to 70. Prior to
programme expansion women aged 50 to 64 were invited for screening under the national cancer screening
programme in England and Wales whereas women in the 65 to 70 age cohort could elect to be screened by
personally organising a screen. This will give a deeper insight into the nature of inequality in screening and the
impact of policies aimed at widening the access related to age on inequality of uptake.
Methods: Taking advantage of this natural experiment, inequality is quantified across the different age cohorts and
time periods with the use of concentration indices (CI). Using data from the British Household Panel Survey,
information on screening attendance, equivalised household income and age was taken for the three years prior to
the programme expansion and the three years immediately following the policy change.
Results: Results show that following the expansion, inequality significantly reduced for the 50-64 age group, prior
to the expansion there was a pro-rich inequality in screening uptake. There is also evidence of a reduction in
income inequality in screening uptake among those aged 65 to 70 and an increase in the number of women
attending screening from this older age cohort.
Conclusions: This indicates that an organised breast screening programme is likely to reduce income related
inequality over a screening programme where women must organise their own screen. This is important when
breast screening is one of the main methods used to detect breast cancer at an earlier stage which improves
outcomes for women and reduces treatment costs.
Keywords: Health economics, Breast screening, Income inequality
Background
The effectiveness and cost-effectiveness of breast cancer
screening has been the subject of debate in recent years [1–
3]. It is argued that, while it is likely to reduce mortality it is
likely to increase morbidity as a result of over-diagnosis.
Cost-effectiveness varies depending on a range of factors in-
cluding assumptions regarding the extent to which screen-
ing advances the diagnosis of cancer and the reduction in
cancer incidence after screening stops. On balance,
evidence appears to support the continued operation of
population based breast cancer screening among specific
age groups based on their relative risk and capacity to bene-
fit [4]. The debate over the value of screening [4–7] how-
ever, draws attention to the sometimes subtle arguments as
well as uncertainties required in assessments of the value of
screening among well-informed independent observers.
Among the public the challenges for informed decision
making are likely to be even greater and it is unclear
what, if any, impact discussion in the literature on the
evidence has on individual decisions of whether or not
to screen. Studies have shown that over half (56%) of
* Correspondence: Ciaran.oneill@qub.ac.uk
2Centre for Public Health, Queens University Belfast, Belfast, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Carney and O’Neill BMC Public Health  (2018) 18:252 
https://doi.org/10.1186/s12889-018-5139-9
breast cancers detected in Britain in 2007 were screen
detected, indicating the programme is successful in en-
gaging women in the relevant age range to screen [8].
The decision of whether or not to screen however, re-
mains the choice of the individual, a choice that requires
the individual to process the information they are pre-
sented with, including that from the cancer screening
programme. The cost of processing and acting on such
information, related to factors such as education [9] and
the opportunity costs of time [10], is unlikely to be dis-
tributed equally across the population. In consequence a
socio-economic gradient might be expected to exist with
those who face greater transaction costs being less likely
to avail of screening.
In Britain, an extension of the programme to include
older women was introduced in 2001, contributing to a
reduction in such barriers among the age group con-
cerned. However, it is unclear whether this would
prompt a disproportionate response among those of
lower socio-economic status, for whom transaction costs
related to organising and availing of a screen might have
been relatively highest, or those from higher socio-
economic groups for whom the cost of processing infor-
mation regarding the value of a screen might have been
relatively low. In consequence one would reasonably ex-
pect any socio-economic gradient prior to the policy
change to be impacted by the expansion of the
programme, though it is not immediately obvious in
which direction the impact might operate. Such an as-
sessment is clearly important in assessing the success, or
otherwise, of a policy intervention in terms of its impact
on equity. That the expansion of the programme and at-
tendant publicity might also be expected to have spill-
over effects among younger women in terms of the
socio-economic profile of women attending also exists
and is worthy of investigation. If peer support contrib-
utes to uptake decisions, a policy that differentially bene-
fits those of a particular socio-economic status might be
reasonably expected to attenuate any socio-economic
gradient among other younger women.
In this paper we estimate and compare the socio-
economic gradient in respect of uptake of breast cancer
screening in Britain before and after an extension of the
eligible age range examining women directly and poten-
tially indirectly affected.
Data
The variables presented in this study are based on data
from the British Household Panel Survey (BHPS) carried
out in Britain from September 1990-August 2008. The
survey was carried out from September of each year
based with questions relating to the previous 12 months.
The BHPS dataset consists of approximately 10,000
interviewed individuals in total, on approximately 5500
households drawn from across Britain, using a stratified
random sampling approach [11]. In this analysis, the
screening behaviour of two sub-samples were examined
and compared.
Breast cancer screening is recommended for women
aged 50 to 70 in the UK. In some areas in the UK women
aged 47 to 49 and 71 to 73 receive invitations for screen-
ing. This is part of a trial to decide if the screening age
should be extended to include women in these age cat-
egories. This is not accounted for in this study. From
programme inception in 1990 until 2000 women aged 50-
64 were invited for screening free of charge every three
years, with the programme being extended to include
women aged 65 to 70 in 2001 in England and Wales and
in 2003 in Scotland [12]. It was announced in 2009 that
Northern Ireland was to follow with the expansion of the
BSP to include women aged 65-70.
Methods
Data were extracted from the BHPS for all women
present in the sample in England and Wales from Sep-
tember 1999 to August 2002, and again all women
present from September 2005 to August 2008. Women
aged 53 to 70 in two time periods were studied; the first
represents screening patterns prior to the expansion of
the screening programme and the second time period is
after the policy change regarding the eligible age range
for screening.
Breast screening is offered on a 3 year cycle commen-
cing at age 50. To capture exposure to screening women
aged 53 to 70 were therefore considered to constitute
the age offered screening. This group were separated
into those aged 53 to 64 and 65 to 70, constituting the
group to whom screens were offered throughout and
those to whom screening was extended respectively.
Equivalised household income (gross) averaged over
two, three year periods was used as the ranking variable
in the construction of the concentration indices (CI).
McClements equivalisation scale was used to divide total
household income which applies a weighting for each in-
dividual in the household. The first adult is accorded a
weight of 0.61, spouse 0.39, other second adult 0.46,
third adult 0.42, and further adult 0.36. Children are al-
located a weighting depending on their age, 0-1 years is
0.09, 2-4 years 0.18, 5-7 years 0.21, 8-10 years is 0.23,
11-12 0.25, 13-15 years 0.27 or 16+ years 0.36. Income is
recorded as a continuous variable in the BHPS. Win-
zorised equivalised household income was used as the
ranking variable. By winzorising the outliers are replaced
with the average of the percentile as oppose to trimming
them away. Income was chosen rather than, for example,
education or employment status as it offered more rank-
ing points across which to estimate a CI. Equivalised
household income was chosen to take account of total
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household income and calls upon this rather than simply
that earned by the individual, this gives a better indica-
tion of socio-economic status. A binary variable is cre-
ated for women that reported having screened at least
once in the three year window observed. The data for
screening in each of the three year periods is pooled.
Data were analysed using a CI in which both Wagstaff
and Erreygers corrections to take account of the dichot-
omous nature of screening uptake (screened in the past
three years yes/no) were estimated [13, 14].
The health CI, as first introduced by Kakwani et al. [15],
Wagstaff et al. [16] and Wagstaff [13], is a summary index
of socio-economic related health inequality. The index is
constructed so as to be bounded between + 1 and − 1; a
negative value is recorded if the health measure of interest
is disproportionately concentrated amongst the poor rela-
tive to their representation in the population and positive
if concentrated amongst the rich. The CI measures health
inequality by using income as its ranking variable and the
health measure, in this case attendance at breast screen-
ing, as the dependent variable [17], thus calculating how
screening is distributed proportionately across the socio-
economic ranking variable, in this case equivalised house-
hold income. Socio-economic related health inequality, in
this instance, refers to variation in uptake of breast screen-
ing among the age group clinically recommended as you
move along the distribution of socio-economic status. The
main condition defining a CI is that it is based on rank or-
dering based solely on the ranking variable.
The CI is contained in eq. (1).
CI ¼ 2
nμh
Xn
i¼1
hiRi−1 ð1Þ
N is population size, hi is health (whether the individ-
ual availed of breast cancer screening), μhis the mean of
the dependent variable (proportion who uptake screen-
ing), Ri = (λi/n) is fractional rank (λi) with respect to the
socio-economic distribution, λi = 1 (poorest), λn = n
(richest). Kakwani et al. [15] illustrated that the standard
error for the CI, illustrated above, can be calculated
using the following eq. (2) to estimate the variance:
var CIð Þ ¼ 1
n
1
n
Xn
i¼1
a2i − 1−CIð Þ2
 !
ð2Þ
The health variable is assumed to be continuous in the
case of the CI, for example childhood height. However, if
the variable being examined is binary, such as if the woman
has gone for a breast screen or not in the previous three
years, the mean of the distribution places limits on the pos-
sible bounds of the CI and therefore the traditional CI is
not bounded between − 1 and + 1. Consequently an ad-
justed index must be used.
Corrections to the CI in the case of dichotomous vari-
ables have been suggested by Wagstaff [13] and Errygers
[14]. Debate has continued in the literature as to which
is the more appropriate correction to use when examin-
ing relative inequality [18].
Normalised Concentration Indices
Wagstaff [13] and Eyyergers’ [14] suggested amending the
traditional CI, as presented above, in order to correct the
bias caused by bounded variables. The correction suggested
by Wagstaff, is outlined in eq. 3 and contains three of the
four properties of rank dependent indices as suggested by
Kjellsson and Gerdtham [18], the mirror property, transfer
and cardinal invariance. The mirror property refers to the
measuring of inequality in both directions and getting the
same index measure. Put simply it means that if you change
the value of the bounded variable around, for example as-
sign a value of 1 to women that don’t screen and 0 to
women that do, then the index would be the same size but
have the opposite sign.
Wagstaff ’s CI is defined as:
ClW ¼ μh bh−ahð Þbh−μhð Þ μh−ahð Þ
2
nμh
Xn
i¼1
hiRi−1
 !
ð3Þ
Also expressed as:
CIw ¼ CI1−μh
ð4Þ
The transfer condition is that the concentration recog-
nises a small transfer of ‘health’ from richer to poorer as a
pro-poor change in the index. Scale invariance is when
the index is not dependent upon the linear formation of
the health variable, so for example if screening was mea-
sured in months or years, this scale invariance condition
allows us to calculate a CI to measure if attendance is
most concentrated among the rich or poor. Kjellsson and
Gerdtham [18] also acknowledge one other property of
some rank dependent inequality indices not met by the
Wagstaff index, level independence. They describe this as
when “an equal increment of health for all individuals
does not affect the index, that is the index is invariant to
scalar addition even when the bounds of the variable are
kept constant.” This is addressed in the CI correction de-
veloped by Erregyers.
CIE ¼ 4μhbh−ahð Þ
2
nμh
Xn
i¼1
hiRi−1
 !
ð5Þ
bh is the upper bound, ah the lower bound, Ri is the
weighted fractional rank of individual i, hi is the health
indicator for individual i and nμhis the proportion of
the population that attend screening in each three
year time period.
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The main relevant differences between the two nor-
malised indices are they report different types of in-
equality; Erreygers’ index measures absolute inequality
and Wagstaff ’s relative inequality.
The second difference between both indices is that
Wagstaff ’s index is bounded by − 1 and + 1, whereas
Erreygers’ index is bounded by
−
bh−μhð Þ μh−ahð Þ
μh bh−ahð Þ
≤CIE ≥ þ bh−μhð Þ μh−ahð Þ
μh bh−ahð Þ
ð6Þ
In this paper we have estimated both Wagstaff and
Erryger’s corrected CIs using the conindex Stata com-
mand written by O’Donnell et al. (2016) [19].
Results
Table 1 contains descriptive statistics for the women in-
cluded in this study for the two time periods, namely
1999-2002 and 2005-2008.
As seen in Table 1 average equivalised household in-
come has increased in the second time period; this is
not surprising as it has not been adjusted for inflation.
There is a marginally higher average number of earners
per household in the latter time period, which may have
an impact on screening attendance. In the second time
period education rates are higher, and slightly fewer
women visit their GP. Fewer in the sample smoke in the
second period and little is changed in self-reported
health and marital status.
Following the expansion breast screening attendance
increased from 37% to 47% within the older cohort in-
cluded in this study. Among the younger group screen-
ing attendance in the first time period was 72%, this
reduced slightly to 69% post expansion. Interestingly in
the second time period a marginally smaller proportion
of the sample attend screening in the 53-64 age categor-
ies. A higher proportion of the older women attend in
the second time period than in the first which is as one
Table 1 Sample Descriptive Statistics for the two time periods
Variable Pre Sample characteristics Post Sample characteristics
Age 53-64
N = 983
Age 53-64
N = 872
Age 65-70
N = 365
Age 65-70 N = 294
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Equivalised Household Income £23,877 (£16,638) £18,706 (£11,235) £29,595 (£18,202) £22,183 (£9690)
Number Earners in Household 1.54 (1.08) 1.53 (1.12) 0.21 (0.50) 0.28 (0.60)
Number dependants under 16 0.045 (0.26) 0.056(0.31) 0.03 (0.25) 0.02 (0.18)
Age 58 (3.16) 59 (3.08) 68 (1.68) 67 (1.74)
Proportion that attend breast screening 72% 69% 37% 47%
Higher Level Education 13% 18% 12% 12%
Secondary Level Education 32% 39% 25% 26%
Primary Level Education 55% 43% 63% 62%
Ten or more GP Visits 13% 11% 13% 12%
6 to 10 GP Visits 14% 13% 14% 15%
3 to 5 GP Visits 21% 22% 30% 23%
1 or 2 GP Visits 33% 32% 29% 35%
0 GP Visits 19% 22% 14% 15%
Smokers 25% 20% 16% 13%
Self-reported health status – Excellent 20% 21% 17% 15%
Self-reported Health Status – Good 43% 44% 43% 45%
Self-reported health status – Fair 24% 24% 28% 27%
Self-reported health status – Poor 10% 8% 8% 11%
Self-Reported Health Status- Very Poor 3% 3% 3% 2%
Marital Status – Married 72% 72% 63% 67%
Marital Status – Separated 1% 1% 0% 1%
Marital Status – Divorced 14% 16% 12% 12%
Marital Status – Widowed 9% 7% 19% 18%
Marital Status – Never Married 4% 4% 6% 2%
SD = Standard Deviation
Carney and O’Neill BMC Public Health  (2018) 18:252 Page 4 of 7
might expect given the expansion of the programme to
include women in this age category. A t-test of the dif-
ference in proportions supported the contention that
there had been an increase in the proportion of older
women in the eligible age range availing of screening
over time.
Figure 1 illustrates breast cancer screening uptake
distributed across equivalised household income quin-
tiles. In both time periods, a higher proportion of
women in the richest income quintiles attend at least
one screen in the three year time period. To give
greater focus to our study and avoid the potential for
confounding associated with different behaviours
across age groups we compare CIs for those aged 53-
64 before the policy change only with those 53-64
after the policy change. Likewise we compare CIs for
those aged 65-70 before the policy change only with
those in this age group afterwards.
Figure 2 above illustrates screening uptake in each in-
come quartile. Prior to the policy change screening at-
tendance is lower among the poorest age categories
though among older women a less obvious relationship
with income is apparent. After the policy change a more
evident pro poor pattern of uptake among the over 65
age category is evident, while among those aged 53-64 a
more equitable pattern of uptake is evident.
In Fig. 1 income distributions are presented for
both age groups before and after the policy change.
The income distributions are more concentrated in
the lower end of the scale for all age groups;
however the skewness appears smaller for the older
age category, the 65-70 age group. This is con-
firmed by the figures in Table 1 where skewness
and the comparison of the mean relative to the me-
dian as well as the standard deviation for older age
cohorts relative to younger cohorts show the more
even distribution of income.
As can be seen in Table 2 the CI results indicate that
in the wake of the policy change less pro-rich patterns of
uptake are evident in both age groups.
Discussion
Among women aged 65-70 while income inequality fell
in the wake of the programme expansion neither the
level of inequality before the policy change nor in its
aftermath was statistically significant. Perhaps surpris-
ingly, given they were not the direct target of the policy,
among women aged 53-64 the pro-rich pattern of uptake
prior to the policy change did change with no statisti-
cally significant gradient in uptake being evident after
the introduction of the change.
The socio-economic gradients and changes in these in
the wake of the policy change are not readily interpret-
able by reference to transaction costs or financial bar-
riers and how these are distributed across the
population. A reduction in transaction costs associated
with organizing a screen and of the financial barriers of
paying for a screen would be expected to disproportion-
ately impact on those who were the target of the policy
change – those aged 65-70 – and among this group
Fig. 1 Equivalised household income distribution for the four samples
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among those with lower incomes for whom barriers
would be most evident in particular. While the degree of
pro-rich inequality is attenuated, changes in the socio-
economic gradient are negligible. By contrast, among
younger women, where a marked pro-rich pattern of up-
take was evident before the policy change, no such gra-
dient is evident in its wake. Why this should be the case
is not entirely clear. Publicity associated with the exten-
sion of the eligible age range may have contributed to
relatively greater uptake among less well-off younger
women though this seems unlikely. Greater uptake
among less well-off older women may have encouraged
greater uptake among less well-off younger women with
whom they are familiar. Such “endorsement” may be
particularly important among those for whom transac-
tion costs are high or among whom health literacy is
low. It is also conceivable that the observed changes
with respect to younger women are unrelated to the pol-
icy change and rather reflect a distinct trend of greater
engagement among less well-off younger women or a
response to other initiatives. The changing pattern of
uptake does point to the potential existence of “spill-
over” effects though it is unclear as to what mechanism
might be at work.
Some caution is warranted in our interpretation of re-
sults. The comparison of uptake before and after the
policy change offers only a crude mechanism by which
to assess its effect. While in principle extending the ana-
lysis to Scotland – which experienced the policy change
later than England and Wales – might offer further evi-
dence, in practice small sample sizes (just 86 women
aged 65-70 in Scotland in BHPS post policy change, for
example), as well as differences in the overall context in
which screening is offered, call into question the merit
of such comparison. More broadly, the sample sizes for
England and Wales underscore the importance of cau-
tion in drawing conclusions from the study. While over-
all the proportion of screening uptake rose and the
socio-economic gradient in uptake fell in the aftermath
of the policy change, caution is warranted in hailing this
Table 2 Concentration Indices
Wagstaff’s Index
(Standard Error)
Erreygers’ Index
(Standard Error)
Pre policy Change England and Wales Women Aged 53-64 (N = 966) 0.097*
(0.04)
0.078*
(0.032)
Pre Policy Change England and Wales Women Aged 65-70 (N = 359) 0.083 (0.063) 0.078 (0.059)
Post Policy Change England and Wales Women Aged 53-64 (N = 872) 0.008 (0.042) 0.007 (0.036)
Post Policy Change England and Wales Women Aged 65-70 (N = 294) −0.03 (0.068) −0.03 (0.068)
* Statistically significant at 95% level
Fig. 2 Screening uptake by income quintile
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as a success given differing income distributions between
the two age groups. Moreover, it is important to note
that we can say nothing from this analysis as to whether
women (and society) benefit from the expansion in
terms of morbidity and mortality reduction.
Conclusion
In the wake of a policy change that extended access to
publicly funded screening, the degree of pro-rich dispar-
ities in uptake fell among age groups covered and un-
covered by the policy change. The reason underlying the
change in behaviour appear to extend beyond financial
barriers related to uptake of screening and suggest fur-
ther research in this area may well prove useful in devel-
oping policies aimed at increasing uptake where
appropriate. Following the expansion of the programme
uptake and greater equity of uptake emerged which
might be considered to provide evidence of its success.
However, why the spill-over effects related to equity
arise is unclear, suggesting some caution is needed hail-
ing the success too strongly and that further research on
its impact is warranted.
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